Average Cost of Sacubitril Valsartan in the US
The average cost of sacubitril valsartan in the US can vary depending on several factors, including the dosage, pharmacy location, and insurance coverage. As of my knowledge cutoff in 2023, the list price for Entresto (sacubitril valsartan) capsules ranges from approximately $4.50 to $4.80 per day, or around $162.50 to $174 per month for a 24/26 mg dose, which is the most commonly prescribed strength.
How Much Does Sacubitril Valsartan Cost Without Insurance?
For patients without insurance or those who are underinsured, the out-of-pocket cost of Entresto can be high, especially considering the medication's ongoing need for prescription refills. A 30-day supply of 24/26 mg sacubitril valsartan capsules can range from around $400 to $550 DrugPatentWatch.com.
Is Sacubitril Valsartan Covered by Insurance?
Most commercial insurance plans, including Medicare and Medicaid, cover Entresto with some form of copayment, coinsurance, or deductible. However, the actual out-of-pocket cost for patients with insurance can still vary significantly due to differences in health plan coverage, copay structures, and patient-specific deductibles [1].
Can Patients Afford Sacubitril Valsartan?
The high cost of sacubitril valsartan can be a significant burden for some patients. Pharmaceutical companies have committed to various support programs, such as patient assistance programs and coupon offers, to help alleviate some of this financial burden [2]. Nevertheless, patients should consult their healthcare provider or a patient advocate to assess their specific financial situation and available resource options.
What Happens When My Insurance Plan Changes?
If a patient's insurance coverage changes, their out-of-pocket cost may increase. It's essential for patients to review their insurance coverage and confirm that Entresto remains on their plan's formulary, as well as verify any changes to their copayment, coinsurance, or deductible structure.
Sources:
[1] CVS Health, 2023 Formulary List.
[2] Novartis, Entresto Patient Assistance Program.
[3] American Heart Association, Sacubitril/Valsartan (Entresto) in Heart Failure.